Want to see HK:9686 full AI Analyst Report?
9686 Stock Chart & Stats
HK$0.90
HK$0.07(8.97%)
At close: 4:00 PM EST
HK$0.90
HK$0.07(8.97%)
Day’s Range― - ―
52-Week RangeHK$0.53 - HK$1.04
Previous CloseN/A
Volume78.50K
Average Volume (3M)60.92K
Market Cap
HK$724.01M
Enterprise ValueHK$489.02
Total Cash (Recent Filing)HK$759.77M
Total Debt (Recent Filing)HK$519.74M
Price to Earnings (P/E)―
Beta0.10
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding841,876,830
10 Day Avg. Volume65,850
30 Day Avg. Volume60,916
Financial Highlights & Ratios
PEG Ratio0.33
Price to Book (P/B)2.17
Price to Sales (P/S)1.47
P/FCF Ratio45.59
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Improving Cash GenerationOperating cash flow turning positive in 2024 and improving into 2025 represents a structural shift from prior multi-year cash burn. Sustained positive OCF reduces reliance on external financing, supports working capital and liability servicing, and supplies a base for reinvestment or gradual deleveraging if maintained.
Balance-sheet RepairEquity returning to positive territory after negative levels in 2020–2022 indicates lasting balance-sheet repair. Positive equity improves solvency cushion, enhances access to capital markets and lender confidence, and provides greater flexibility to manage cyclical downturns or fund strategic initiatives over the medium term.
Narrowing LossesMaterial narrowing of losses versus prior years and strong EPS improvement point to improving operational performance. If cost control and margin trends continue, the company can move toward break-even and eventual profitability, reducing cash burn and creating a more sustainable business model over coming quarters.
Bears Say
Contracting RevenueConsecutive years of revenue decline weaken operating leverage and long-term growth potential. Shrinking top-line makes it harder to cover fixed costs, compresses margins, and raises the bar for achieving sustained profitability; recovery will require durable revenue stabilization or new growth drivers.
High LeverageMeaningful leverage with debt exceeding equity constrains strategic options and increases financial risk. High indebtedness raises interest and refinancing vulnerability, limits capacity for capex or M&A, and amplifies downside if cash flows deteriorate, making a durable recovery more difficult without debt reduction.
Profitability & FCF VolatilityOngoing operating losses and volatile free cash flow—positive one year then roughly breakeven—signal inconsistent cash generation. This limits reinvestment and deleveraging ability, heightens reliance on external funding, and raises the risk that occasional improvements may not translate into durable financial stability.
NEUSOFT XIKANG HOLDINGS INC. News
9686 FAQ
What was NEUSOFT XIKANG HOLDINGS INC.’s price range in the past 12 months?
NEUSOFT XIKANG HOLDINGS INC. lowest stock price was HK$0.53 and its highest was HK$1.04 in the past 12 months.
What is NEUSOFT XIKANG HOLDINGS INC.’s market cap?
NEUSOFT XIKANG HOLDINGS INC.’s market cap is HK$724.01M.
When is NEUSOFT XIKANG HOLDINGS INC.’s upcoming earnings report date?
NEUSOFT XIKANG HOLDINGS INC.’s upcoming earnings report date is Aug 27, 2026 which is in 19 days.
How were NEUSOFT XIKANG HOLDINGS INC.’s earnings last quarter?
NEUSOFT XIKANG HOLDINGS INC. released its earnings results on Mar 19, 2026. The company reported HK$0.013 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is NEUSOFT XIKANG HOLDINGS INC. overvalued?
According to Wall Street analysts NEUSOFT XIKANG HOLDINGS INC.’s price is currently Overvalued.
Does NEUSOFT XIKANG HOLDINGS INC. pay dividends?
NEUSOFT XIKANG HOLDINGS INC. does not currently pay dividends.
What is NEUSOFT XIKANG HOLDINGS INC.’s EPS estimate?
NEUSOFT XIKANG HOLDINGS INC.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NEUSOFT XIKANG HOLDINGS INC. have?
NEUSOFT XIKANG HOLDINGS INC. has 841,876,830 shares outstanding.
What happened to NEUSOFT XIKANG HOLDINGS INC.’s price movement after its last earnings report?
NEUSOFT XIKANG HOLDINGS INC. reported an EPS of HK$0.013 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5%.
Which hedge fund is a major shareholder of NEUSOFT XIKANG HOLDINGS INC.?
Currently, no hedge funds are holding shares in HK:9686
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
NEUSOFT XIKANG HOLDINGS INC. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
40.00%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-5.26%
Trailing 12-Months
Company Description
NEUSOFT XIKANG HOLDINGS INC.
Xikang Cloud Hospital Holdings Inc. specializes in constructing customized digital healthcare platforms designed for urban settings. Its business operations are structured into four main categories: Cloud Hospital Platform Services, Internet Medical Services, Health Management Services, and Smart Healthcare Products. The Cloud Hospital Platform Services unit provides advanced technological solutions to local governmental bodies, medical institutions, and insurance providers. Through its Internet Medical Services, the company offers a range of options including virtual hospital consultations, remote medical support, intelligent family physician initiatives, and online home care assistance. The Health Management Services division delivers comprehensive wellness oversight and specific chronic condition management programs. Lastly, the Smart Healthcare Products segment markets innovative health-related devices to a broad customer base, encompassing municipal authorities, primary care facilities, businesses, and individual consumers. The company was founded on May 12, 2011, and its headquarters are situated in Shanghai, China.
Technical Analysis
EC Healthcare
―
Beijing Airdoc Technology Co. Ltd. Class H
―
Yonghe Medical Group Co., Ltd.
―
Town Health International Medical Group Ltd.
―
UMP Healthcare Holdings Limited
―